New antibody infusion shows promise for immune deficiency patients
NCT ID NCT03961009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new intravenous immunoglobulin (IVIg) treatment called Kedrion IVIg 10% in 47 people with primary immunodeficiency, a condition where the immune system cannot make enough antibodies. The goal was to see if regular infusions of this antibody therapy could prevent serious infections and maintain safe antibody levels. The trial is now complete, and results will show how well the treatment works and how safe it is.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Kedrion intravenous immunoglobulin (IVIg) 10%
- What this could lead to
- If successful, this could provide a safe and effective antibody replacement therapy for people with primary immunodeficiency, helping them fight infections.
- What could go wrong
- This is a small, completed Phase 3 trial with only 47 participants, so results may not apply to all patients. IVIg therapy requires regular infusions and can cause side effects like headache, fever, or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AARA Research Center
Dallas, Texas, 75231, United States
-
Allergy Associates of the Palm Beaches
North Palm Beach, Florida, 33408, United States
-
Allergy Partners of North Texas Research
Dallas, Texas, 75230, United States
-
Allergy and Immunology Associates
Little Silver, New Jersey, 07739, United States
-
Dr. Henry J. Kanarek - Allergy, Asthma & Immunology
Overland Park, Kansas, 66211, United States
-
Midwest Immunology Clinic and Infusion Center
Plymouth, Minnesota, 55446, United States
-
Ohio Clinical Research Associates, Inc.
Mayfield Heights, Ohio, 44124, United States
-
Optimed Research
Columbus, Ohio, 43235, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Toledo Institute of Clinical Research Inc
Toledo, Ohio, 43617, United States
-
University of Buffalo
Buffalo, New York, 14203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.